Literature DB >> 9093881

Stem cell antigen 2 expression in adult and developing mice.

M Antica1, L Wu, R Scollay.   

Abstract

Stem cell antigen 2 (Sca-2) expression can distinguish the most immature T-lymphocyte precursors in the thymus from the hemopoietic stem cells. Sequence analysis of the Sca-2 protein showed that Sca-2 is a glycosylphosphatidylinositol (GPI) anchored molecule that shares some characteristics with the members of the Ly-6 multigene family, and that it is the same as the thymic shared antigen-1 (TSA-1). Here we extend these studies and critically reassess the expression of the Sca-2/TSA-1 antigen in hematopoietic tissues of adult and developing mice. With more sensitive methods we show that the distribution of Sca-2/TSA-1 differs from existing reports. We find especially high expression of Sca-2/TSA1 at day 14 of fetal development.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9093881     DOI: 10.1016/s0165-2478(96)02682-x

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  10 in total

1.  Essential role for the lymphostromal plasma membrane Ly-6 superfamily molecule thymic shared antigen 1 in development of the embryonic adrenal gland.

Authors:  David J Zammit; Stuart P Berzins; Jason W Gill; Elise S Randle-Barrett; Louise Barnett; Frank Koentgen; Gavin W Lambert; Richard P Harvey; Richard L Boyd; Brendan J Classon
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

2.  Stem cell antigen 2: a new gene involved in the self-renewal of erythroid progenitors.

Authors:  C Bresson-Mazet; O Gandrillon; S Gonin-Giraud
Journal:  Cell Prolif       Date:  2008-10       Impact factor: 6.831

Review 3.  Detection of circulating tumor cells in prostate cancer patients: methodological pitfalls and clinical relevance.

Authors:  Zacharoula Panteleakou; Peter Lembessis; Antigone Sourla; Nikolaos Pissimissis; Aristides Polyzos; Charalambos Deliveliotis; Michael Koutsilieris
Journal:  Mol Med       Date:  2008-12-03       Impact factor: 6.354

Review 4.  Prostate cancer relevant antigens and enzymes for targeted drug delivery.

Authors:  Ashutosh Barve; Wei Jin; Kun Cheng
Journal:  J Control Release       Date:  2014-05-27       Impact factor: 9.776

5.  Deletion of the Syncytin A receptor Ly6e impairs syncytiotrophoblast fusion and placental morphogenesis causing embryonic lethality in mice.

Authors:  Michael B Langford; Jennifer E Outhwaite; Martha Hughes; David R C Natale; David G Simmons
Journal:  Sci Rep       Date:  2018-03-02       Impact factor: 4.379

6.  LY6E: a conductor of malignant tumor growth through modulation of the PTEN/PI3K/Akt/HIF-1 axis.

Authors:  Chan Joo Yeom; Lihua Zeng; Yoko Goto; Akiyo Morinibu; Yuxi Zhu; Kazumi Shinomiya; Minoru Kobayashi; Satoshi Itasaka; Michio Yoshimura; Cheol-Goo Hur; Hideaki Kakeya; Ester M Hammond; Masahiro Hiraoka; Hiroshi Harada
Journal:  Oncotarget       Date:  2016-10-04

7.  LY6E mediates an evolutionarily conserved enhancement of virus infection by targeting a late entry step.

Authors:  Katrina B Mar; Nicholas R Rinkenberger; Ian N Boys; Jennifer L Eitson; Matthew B McDougal; R Blake Richardson; John W Schoggins
Journal:  Nat Commun       Date:  2018-09-06       Impact factor: 14.919

Review 8.  A piece in prostate cancer puzzle: Future perspective of novel molecular signatures.

Authors:  Anmar M Nassir
Journal:  Saudi J Biol Sci       Date:  2020-02-10       Impact factor: 4.219

9.  Monitoring luciferase-labeled human prostate stem cell antigen-expressing tumor growth in a mouse model.

Authors:  Lei Dong; Xiaopeng Zhang; Changming Yu; Ting Yu; Shuling Liu; Lihua Hou; Ling Fu; Shaoqiong Yi; Wei Chen
Journal:  Exp Ther Med       Date:  2013-09-13       Impact factor: 2.447

Review 10.  Characterization and function of human Ly-6/uPAR molecules.

Authors:  Hyun Kyung Kong; Jong Hoon Park
Journal:  BMB Rep       Date:  2012-11       Impact factor: 4.778

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.